Results 31 to 40 of about 5,617 (179)
X-linked agammaglobulinemia: Experience in a Portuguese hospital
Anales De Pediatría (English Edition), 2015 X-Linked agammaglobulinemia (XLA) is characterized by an arrest of B cell differentiation, leading to recurrent bacterial infections. Lifelong immunoglobulin replacement therapy (IRT) is indicated to prevent infections and their complications.A retrospective study of patients with XLA followed in a level three hospital was performed; data was collected
Susana Fernandes
exaly +3 more sources
Gastric adenocarcinoma in a patient with X-linked agammaglobulinemia and HIV: Case report and review of the literature [PDF]
Frontiers in Pediatrics, 2016 X-linked agammaglobulinemia (XLA) is an X-linked inherited disease usually caused by a germline mutation in the BTK gene leading to Bruton’s tyrosine kinase deficiency, which results in the impaired development of B-lymphocytes and a subsequent lack of ...
Joud Hajjar +4 more
doaj +2 more sources
The quality of life of children and adolescents with X-linked agammaglobulinemia [PDF]
, 2009 The health-related quality of life in X-linked agammaglobulinemia was investigated in 25 children and adolescents patients through the Italian version of Pediatric Quality of Life Inventory 4.0 Generic Core Scale for patients aged less then 18 years ...
Franco, Locatelli
core +9 more sources
Current Spectrum of Infections in Patients with X-Linked Agammaglobulinemia [PDF]
, 2021 International audienceOutcome of patients with X-linked agammaglobulinemia (XLA) has improved with the widespread use of immunoglobulin replacement therapy (IgRT).
Neven, Bénédicte +12 more
core +1 more source
Revista Peruana de Medicina Experimental y Salud Pública, 2019 Primary agammaglobulinemia result from specific alterations in B cells, which lead to low antibody production. Diagnostic suspicion is established with a history of repeated infections, low immunoglobulins, and absence of CD19+ B lymphocytes.
Edgar Matos-Benavides +4 more
doaj +1 more source
Медицинский вестник Юга России, 2020 Objective: to evaluate the effectiveness of intravenous immunoglobulins in X-linked agammaglobulinemia, to identify changes in the cellular link of the innate and adaptive immune response associated with an insufficient effect of replacement therapy ...
L. P. Sizyakina +2 more
doaj +1 more source
Campylobacter jejuni Pericarditis: A Case Report
Acta Médica Portuguesa, 2022 Campylobacter jejuni is one of the most common causes of enteritis. In rare cases, extraintestinal infection can occur, with a handful of cases of cardiac involvement, of which the pathophysiological mechanism is unclear.
Joao Neves-Maia +3 more
doaj +1 more source
SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia. [PDF]
Pediatr Infect Dis J, 2021 We present a case of a 17-year-old boy with X-linked agammaglobulinemia who had mild disease when initially infected with SARS-CoV-2 but after recovering from acute infection developed fevers and a raised erythrocyte sedimentation rate that persisted for
Pereira NMD +5 more
europepmc +3 more sources
Clinical Immunology and Immunopathology, 1991 X-linked agammaglobulinemia (XLA) patients manifest a very low production of immunoglobulins (Ig) of all classes and plasma cells are virtually absent. The XLA gene plays a crucial role in the transition of pre-B cells to later B cell stages, as hardly any slg-positive B lymphocytes can be detected.
E, Timmers +4 more
openaire +2 more sources
Carbapenem resistant Campylobacter jejuni bacteremia in a Bruton's X-linked agammaglobulinemia patient. [PDF]
Eur J Clin Microbiol Infect DisImmunocompromised patients are prone to recurrent Campylobacter infections. We report a case of recurrent multi-drug resistant Campylobactor jejuni bloodstream infections in a Bruton's X-linked agammaglobulinemia patient with prolonged ertapenem ...
Zhuo R, Younes RL, Ward K, Yang S.
europepmc +3 more sources